ClinicalTrials.Veeva

Menu

Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy.

C

Centre of Postgraduate Medical Education

Status

Completed

Conditions

Prostate Cancer

Treatments

Drug: 30 milliliters of 0.375% Ropivacaine
Drug: 30 milliliters of 0.9% NaCl
Procedure: Qadratus Lumborum Block

Study type

Interventional

Funder types

Other

Identifiers

NCT03600129
83/PB/2018

Details and patient eligibility

About

Laparoscopic prostatectomy (LP) is characterized by substantial tissue trauma, despite its minimally -invasive approach. Although postoperative pain intensity is lower when compared to open procedures, the use of opioids is common. Retrospective review of available LP cases revealed that although analgesic demand varied, nearly all of our LP patients required opioids postoperatively. Bilateral Quadratus Lumborum Block (QLB), being one of relatively new features of regional anesthesia, offers good analgesia of abdominal wall, with the potential for control of visceral pain. This study was established to evaluate its effectiveness in alleviating pain after radical prostatectomy in a double - blind, placebo - controlled manner.

Enrollment

50 patients

Sex

Male

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA status less or equal 3
  • Scheduled for transperitoneal or extraperitoneal endoscopic prostatectomy
  • Able to understand information provided and to sign the informed consent for participation in the study

Exclusion criteria

  • known allergy to local anesthetics and opioids
  • infection in the area of block placement
  • known chronic use of opioids, gabapentinoids and tricyclic antidepressants
  • mental inability to understand the principles and rules of patient-controlled analgesia pump

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

50 participants in 2 patient groups, including a placebo group

QLB with 0,375% ropivacaine
Experimental group
Treatment:
Drug: 30 milliliters of 0.375% Ropivacaine
Procedure: Qadratus Lumborum Block
QLB with 0,9% NaCl
Placebo Comparator group
Treatment:
Procedure: Qadratus Lumborum Block
Drug: 30 milliliters of 0.9% NaCl

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems